Read + Share

Amedeo Smart

Independent Medical Education


Read + Share

Liu YL, Mathews CA, Simpkins F, Cadoo KA, et al. Olaparib as treatment for platinum-sensitive relapsed ovarian cancer by BRCA mutation and homologous recombination deficiency: Phase 2 LIGHT study final overall survival analysis. Cancer 2025;131:e35707.
PMID: 39817648


Privacy Policy